Jessica Ziemek

A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin.

L. Rice, Julio C. Mantero, Giuseppina Stifano, 2017, The Journal of investigative dermatology.

Local skin gene expression reflects both local and systemic skin disease in patients with systemic sclerosis.

L. Rice, Giuseppina Stifano, Jessica Ziemek, 2015, Rheumatology.

The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis.

Jessica Ziemek, R. Simms, J. Varga, 2016, Rheumatology.

Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis

D. Felson, Jessica Ziemek, R. Simms, 2017, Annals of the rheumatic diseases.

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.

M. Whitfield, L. Rice, Jessica Ziemek, 2015, The Journal of clinical investigation.

miR-155 in the progression of lung fibrosis in systemic sclerosis

Giuseppina Stifano, Jessica Ziemek, R. Simms, 2016, Arthritis Research & Therapy.

A Longitudinal Biomarker for the Extent of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis

M. Whitfield, L. Rice, Giuseppina Stifano, 2015, Arthritis & rheumatology.

Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial.

Julio C. Mantero, Giuseppina Stifano, Jessica Ziemek, 2018, Clinical and experimental rheumatology.

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.

M. Whitfield, L. Rice, Jessica Ziemek, 2015, The Journal of clinical investigation.